|Awarded On||August 20, 2014|
|Title||New Technology for Ultra High Throughput Enumeration of Circulating Tumor Cells|
|Award Mechanism||High Impact/High Risk|
|Institution/Organization||Texas Tech University|
|Principal Investigator/Program Director||Siva Vanapalli|
|Cancer Sites||All Sites|
Circulating tumor cells (CTCs) in blood flow have been recognized to be the primary drivers of metastasis in cancer. Recently sensitive devices have been developed that allow detection of these tumor cells in the blood of cancer patients. This so called liquid biopsy approach has game-changing potential for cancer diagnosis, prognosis and personalized chemotherapy treatments. Despite the enormous potential of this liquid-biopsy approach, progress in CTC-related basic and clinical research has been hindered because of their extremely low counts (1-10 CTCs in 1 billion blood cells), highly heterogeneous morphologies and molecular expression profiles that depend on the type of cancer. In this p...